Intraocular Lens Market to Witness Transformational Growth Opportunities by 2032 – DelveInsight | Johnson & Johnson, Alcon, Bausch & Lomb, ZEISS Group, STAAR Surgical, Hoya Corporation
DelveInsight’s “Intraocular Lens Market Insights, Competitive Landscape, and Market Forecast – 2032” report offers an in-depth understanding of the Intraocular Lens market, historical and forecasted market trends across North America, Europe, Asia-Pacific, and the Rest of the World.
The latest healthcare forecast report provides a comprehensive analysis of the Intraocular Lens market, offering detailed insights into revenue trends, prevalence of eye-related disorders, and the evolving treatment landscape. The report examines key market statistics, highlighting current and projected market size, while assessing the efficacy and development of emerging IOL technologies. Additionally, it covers recent product developmental activities, regulatory approvals, and strategic initiatives undertaken by leading companies — making it an essential resource for understanding the dynamics and future direction of the global intraocular lens market.
Get a Free Sample for the Intraocular Lens Market Forecast, Size & Share Analysis Report: https://www.delveinsight.com/report-store/intraocular-lens-market
Some of the Key Facts of the Intraocular Lens Market Report:
-
The Global Intraocular Lens Market was valued at USD 4,648.96 million in 2024 and is anticipated to grow to nearly USD 7,414.66 million by 2032, registering a CAGR of approximately 6.12% during the forecast period from 2025 to 2032.
-
In May 2025, Alcon announced that its Vivity® intraocular lens — the most widely implanted extended depth of focus (EDOF) IOL — is now available on its most advanced lens material, Clareon®. The Clareon Vivity® received CE Mark approval and commenced commercial rollout across Europe in early Q2 2025.
-
In May 2025, Eye health company Bausch + Lomb received CE Mark approval in Europe for its LuxLife range of intraocular lenses (IOLs), marking a key milestone in expanding its vision correction portfolio.
-
In October 2024, Johnson & Johnson announced the expanded availability of its TECNIS Odyssey intraocular lens (IOL) across the United States.
-
In October 2024, Bausch + Lomb Corporation announced that the U.S. Food and Drug Administration approved the enVista® Envy™ full range of vision intraocular lens (IOL).
-
The Extended Depth-Of-Focus (EDOF) category within the Premium IOLs segment is projected to capture a significant revenue share in 2024, driven by high patient satisfaction levels and growing spectacle independence.
-
North America is expected to dominate the overall Intraocular Lens market in 2024, supported by a large patient pool, sophisticated healthcare infrastructure, and robust product developmental activities.
-
According to the American Academy of Ophthalmology (2024), 33% of people in the US have astigmatism, and 14 million Americans aged 40 and above are affected with hypermetropia.
-
According to the Canadian Council of the Blind (2022), approximately 1.2 million Canadians suffered vision loss in 2020, a figure projected to surge to 1.58 million by 2030.
-
Globally, approximately 224 million individuals — nearly 3% of the global population — suffer from severe myopia, with projections suggesting almost half the world’s population (5 billion people) could be myopic by 2050.
-
Late teenagers and young adults in countries like Korea, Taiwan, and China already face myopia prevalence rates ranging from 84% to 97%, according to Vision Center (2024).
-
Key Intraocular Lens Companies: Johnson & Johnson Services, Inc., Hoya Corporation, ALCON INC., ZEISS Group, Rayner Intraocular Lenses Limited, Eyekon Medical Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Aurolab, PhysIOL SA, Care Group, TEKIA, Inc., Omni Lens Pvt Ltd., MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt Ltd., Bausch & Lomb Incorporated, Hanita Lens, and others.
-
Key Intraocular Lens Types: Monofocal IOLs (Aspheric and Spheric), Premium IOLs (Multifocal, Accommodating, and Extended Depth-Of-Focus), across materials including PMMA, Hydrophobic Acrylic, and Hydrophilic Acrylic.
-
The Intraocular Lens market is expected to surge due to growing cases of eye-related disorders, increased awareness and accessibility to eye care, technological advancements in lens materials and designs, and increased product development activities during the forecast period.
Intraocular Lens Market Overview
An intraocular lens (IOL) is an artificial lens implanted in the eye, most commonly used to replace the natural lens during cataract surgery or as a standalone refractive correction procedure. IOLs correct a range of vision disorders including cataracts, presbyopia, astigmatism, myopia, and hypermetropia. Types include monofocal lenses for single-distance correction and premium lenses — such as multifocal, accommodating, and extended depth-of-focus (EDOF) options — designed to restore a broader range of vision. Technological advancements in lens materials and designs continue to improve patient outcomes and satisfaction.
To Know in detail about the Intraocular Lens market outlook, treatment scenario, and key growth drivers, Click here; Intraocular Lens Market Forecast
Intraocular Lens Market Dynamics
The intraocular lens market is being significantly boosted by the growing global burden of eye-related disorders. The rising prevalence of myopia, particularly high myopia, is significantly driving demand for IOLs as more individuals face vision impairment at younger ages. Lifestyle factors such as increased screen time and urbanization are further amplifying this trend, prompting earlier interventions. Government initiatives, such as the August 2022 global awareness campaign launched by the International Agency for the Prevention of Blindness (IAPB), are also reinforcing the importance of accessible eye care for approximately 1 billion people worldwide who currently lack treatment for poor vision.
Additionally, ongoing technological advancements in lens materials and designs — including the development of multifocal, toric, and extended depth-of-focus lenses — are enhancing visual outcomes and patient satisfaction. Increased product development and regulatory approvals by key market players are introducing innovative, customized IOL solutions, collectively accelerating market growth. Despite these promising drivers, post-operative complications associated with IOLs and limited insurance coverage for premium lenses remain significant barriers that could constrain market expansion during the forecast period.
Intraocular Lens Market Segmentation
Intraocular Lens Market by Type: Monofocal IOL (Aspheric Monofocal IOLs and Spheric Monofocal IOLs), Premium IOLs (Multifocal IOLs, Accommodating IOLs, and Extended Depth-Of-Focus (EDoF) IOLs), and Others
Intraocular Lens Market by Material: Polymethyl Methacrylate (PMMA), Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others
Intraocular Lens Market by End-User: Hospitals, Ambulatory Surgical Centres, and Ophthalmology Clinics
Intraocular Lens Market by Geography: North America, Europe, Asia-Pacific, and Rest of the World
Download the report to understand which factors are driving Intraocular Lens market trends @ Intraocular Lens Market Forecast
Intraocular Lens Market Drivers
-
Growing cases of eye-related disorders such as cataracts, presbyopia, and astigmatism are increasing the demand for corrective surgical interventions globally.
-
Improved awareness and accessibility to eye care services, especially in developing regions, are enabling more patients to seek timely treatment.
-
Ongoing technological advancements in IOL materials and designs — including multifocal, toric, and EDOF lenses — are enhancing visual outcomes and patient satisfaction.
-
Increased product development activities and strategic initiatives by key market players are introducing innovative and customized IOL solutions.
-
Rising prevalence of high myopia worldwide is driving demand for advanced corrective solutions, with IOLs becoming a key option for long-term vision correction.
Intraocular Lens Market Barriers
-
Post-operative complications associated with intraocular lenses remain a significant clinical and commercial constraint.
-
Limited insurance coverage and reimbursement for premium IOLs may restrict patient access to advanced lens technologies.
-
High costs of premium lens categories may hinder adoption, particularly in price-sensitive emerging markets.
Scope of the Intraocular Lens Market Report
-
Study Period: 2025–2032
-
Coverage: Global
-
CAGR: ~6.12%
-
Market Size (2032): ~USD 7,414 Million
-
Base Year Value (2024): USD 4,648.96 Million
-
Key Companies: Johnson & Johnson, Alcon, Bausch + Lomb, ZEISS Group, Hoya Corporation, STAAR Surgical, Rayner, and others.
To know more about Intraocular Lens companies and competitive landscape, visit @ Intraocular Lens Market Companies and Competitive Assessment
Table of Contents
-
Intraocular Lens Market Report Introduction
-
Intraocular Lens Market Executive Summary
-
Competitive Landscape
-
Regulatory Analysis
-
Intraocular Lens Market Key Factors Analysis
-
Intraocular Lens Market Porter’s Five Forces Analysis
-
Intraocular Lens Market Assessment
-
Intraocular Lens Market Company and Product Profiles
-
KOL Views
-
Project Approach
-
About DelveInsight
-
Disclaimer & Contact Us
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma and MedTech companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefit market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/intraocular-lens-market
